Cystic Fibrosis Foundation distributed the following clinical trial update in March. Click the trial title to get more details.
March 11, 2019
Description: This study will look at the effectiveness of the inhaled drug molgramostim, a drug intended to treat infections in the lung.
Age: 18 Years and Older
Mutation: No Mutation Requirement
Fev1% Predicted: 30% or greater
Number of Visits: 19
Length of Participation: 72 weeks
ClinicalTrials.gov link: https://clinicaltrials.gov/ct2/show/NCT03597347